BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25795305)

  • 21. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
    Moskalev EA; Frohnauer J; Merkelbach-Bruse S; Schildhaus HU; Dimmler A; Schubert T; Boltze C; König H; Fuchs F; Sirbu H; Rieker RJ; Agaimy A; Hartmann A; Haller F
    Lung Cancer; 2014 Jun; 84(3):215-21. PubMed ID: 24674157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer.
    Lira ME; Choi YL; Lim SM; Deng S; Huang D; Ozeck M; Han J; Jeong JY; Shim HS; Cho BC; Kim J; Ahn MJ; Mao M
    J Mol Diagn; 2014 Mar; 16(2):229-43. PubMed ID: 24418728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset.
    Guo Y; Ma J; Lyu X; Liu H; Wei B; Zhao J; Fu S; Ding L; Zhang J
    BMC Cancer; 2014 Nov; 14():834. PubMed ID: 25407901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions.
    Yeh I; de la Fouchardiere A; Pissaloux D; Mully TW; Garrido MC; Vemula SS; Busam KJ; LeBoit PE; McCalmont TH; Bastian BC
    Am J Surg Pathol; 2015 May; 39(5):581-91. PubMed ID: 25602801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel KIF5B-ALK variant in nonsmall cell lung cancer.
    Wong DW; Leung EL; Wong SK; Tin VP; Sihoe AD; Cheng LC; Au JS; Chung LP; Wong MP
    Cancer; 2011 Jun; 117(12):2709-18. PubMed ID: 21656749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.
    Betz BL; Dixon CA; Weigelin HC; Knoepp SM; Roh MH
    Cancer Cytopathol; 2013 Sep; 121(9):489-99. PubMed ID: 23536384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC).
    Kotoula V; Bobos M; Vassilakopoulou M; Tsolaki E; Chrisafi S; Psyrri A; Lazaridis G; Papadopoulou K; Efstratiou I; Michail-Strantzia C; Debelenko LV; Kosmidis P; Fountzilas G
    Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):60-70. PubMed ID: 25153496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
    Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
    Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
    Van Roosbroeck K; Cools J; Dierickx D; Thomas J; Vandenberghe P; Stul M; Delabie J; De Wolf-Peeters C; Marynen P; Wlodarska I
    Haematologica; 2010 Mar; 95(3):509-13. PubMed ID: 20207848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ependymoma-like tumor with mesenchymal differentiation (ELTMD) with ZFTA:NCOA1 fusion: A diagnostic challenge.
    Dorwal P; White C; Goh AF; Kumar A; McEniery J; Walker R; Robertson T
    Neuropathology; 2024 Jun; 44(3):216-221. PubMed ID: 37931917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
    Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
    Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors.
    Patel AS; Murphy KM; Hawkins AL; Cohen JS; Long PP; Perlman EJ; Griffin CA
    Cancer Genet Cytogenet; 2007 Jul; 176(2):107-14. PubMed ID: 17656252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare.
    Zhao W; Choi YL; Song JY; Zhu Y; Xu Q; Zhang F; Jiang L; Cheng J; Zheng G; Mao M
    Lung Cancer; 2016 Apr; 94():22-7. PubMed ID: 26973202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease.
    Lawrence K; Berry B; Handshoe J; Hout D; Mazzola R; Morris SW; Saltman DL
    BMC Res Notes; 2015 Jul; 8():308. PubMed ID: 26187744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel fusion of TPR and ALK in lung adenocarcinoma.
    Choi YL; Lira ME; Hong M; Kim RN; Choi SJ; Song JY; Pandy K; Mann DL; Stahl JA; Peckham HE; Zheng Z; Han J; Mao M; Kim J
    J Thorac Oncol; 2014 Apr; 9(4):563-6. PubMed ID: 24736082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
    Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
    Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization.
    Scheil S; Brüderlein S; Eicker M; Herms J; Herold-Mende C; Steiner HH; Barth TF; Möller P
    Brain Pathol; 2001 Apr; 11(2):133-43. PubMed ID: 11303789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancers with concomitant EGFR mutations and ALK rearrangements: diverse responses to EGFR-TKI and crizotinib in relation to diverse receptors phosphorylation.
    Yang JJ; Zhang XC; Su J; Xu CR; Zhou Q; Tian HX; Xie Z; Chen HJ; Huang YS; Jiang BY; Wang Z; Wang BC; Yang XN; Zhong WZ; Nie Q; Liao RQ; Mok TS; Wu YL
    Clin Cancer Res; 2014 Mar; 20(5):1383-92. PubMed ID: 24443522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
    Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
    Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma.
    Feldman AL; Vasmatzis G; Asmann YW; Davila J; Middha S; Eckloff BW; Johnson SH; Porcher JC; Ansell SM; Caride A
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1097-102. PubMed ID: 23999969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.